Home › Asset managers › Dimensional › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Dimensional voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
6,035 proposals. The board-sponsored half of this list keeps the 6,000 proposals with the most funds behind them; the rest are in the interactive database. Every shareholder proposal it backed is listed in full.
| Company | Meeting | Proposal | Category | On the ballot from | Board recommended | Dimensional voted | Funds |
|---|---|---|---|---|---|---|---|
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Issuance of Shares for Raising Supporting Funds - Lock-Up Period | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Issuance of Shares for Raising Supporting Funds - Pricing Reference Date, Pricing Principles and Issue Price | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Issuance of Shares for Raising Supporting Funds - Use of Proceeds | Capital Structure | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Proposal on Whether This Transaction Constitutes a Major Asset Restructuring and a Restructuring Listing | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Report (Draft) and Summary on Company's Issuance of Shares and Acquisition by Cash as well as Raising Supporting Funds and Related Party Transactions | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Resolution Validity Period | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Signing of Supplementary Agreement to the Agreement on Issuance of Shares and Acquisition by Cash, and Performance Commitment and Impairment Compensation Agreement | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve The Company Does Not Exist in Article 11 of the Administrative Measures for the Registration of Securities Issuance by Listed Companies | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Transaction Complies with Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve Transaction Complies with Articles 11, 43 and 44 of the Measures for the Administration of Major Asset Restructuring of Listed Companies | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tianshui Huatian Technology Co., Ltd. | February 27, 2026 | Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 | Extraordinary Transactions | Board | AGAINST | 5 | |
| Tibet Summit Resources Co. Ltd. | June 22, 2026 | Approve Authorization of the Board to Handle All Related Matters | Compensation | Board | AGAINST | 5 | |
| Tibet Summit Resources Co. Ltd. | June 22, 2026 | Approve Draft and Summary of Employee Share Purchase Plan | Compensation | Board | AGAINST | 5 | |
| Tibet Summit Resources Co. Ltd. | June 22, 2026 | Approve Methods to Assess the Performance of Plan Participants | Compensation | Board | AGAINST | 5 | |
| Tongcheng Travel Holdings Limited | June 16, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| Tongcheng Travel Holdings Limited | June 16, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 5 | |
| Tongda Group Holdings Limited | May 29, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| Tongda Group Holdings Limited | May 29, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 5 | |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | May 12, 2026 | Approve Provision of Financial Assistance | Capital Structure | Board | AGAINST | 5 | |
| Tradeweb Markets Inc. | May 19, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| TransAct Technologies Incorporated | May 26, 2026 | Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| TransMedics Group, Inc. | May 20, 2026 | To approve an amendment to the TransMedics Group, Inc.'s Amended and Restated 2019 Stock Incentive Plan to increase the maximum aggregate number of shares of common stock that may be issued pursuant to awards granted under the TransMedics Group, Inc. Amended and Restated 2019 Stock Incentive Plan by 2,750,000 shares and make certain other changes as set forth in the proxy statement. | Compensation | Board | AGAINST | 5 | |
| Transcontinental Inc. | March 10, 2026 | Elect Director Mario Plourde | Director Elections | Board | AGAINST | 5 | |
| Transport International Holdings Limited | May 14, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| Transport International Holdings Limited | May 14, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | December 29, 2025 | Approve Comprehensive Financing and Provision of Guarantee | Capital Structure | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Authorization of the Board to Handle All Matters Related to the Employee Share Purchase Plan | Compensation | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Authorization of the Board to Handle All Matters Related to the Performance Share Incentive Plan | Compensation | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Draft and Summary of Performance Share Incentive Plan | Compensation | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Draft and Summary on Employee Share Purchase Plan | Compensation | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Management Measures for Employee Share Purchase Plan | Compensation | Board | AGAINST | 5 | |
| Trina Solar Co., Ltd. | February 9, 2026 | Approve Methods to Assess the Performance of Plan Participants | Compensation | Board | AGAINST | 5 | |
| Triple Flag Precious Metals Corp. | May 6, 2026 | Elect Director Dawn Whittaker | Director Elections | Board | AGAINST | 5 | |
| Twilio Inc. | June 16, 2026 | To approve the Twilio Inc. Amended and Restated 2016 Stock Option and Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Twist Bioscience Corporation | February 5, 2026 | Election of Class II Directors: Jan Johannessen | Director Elections | Board | WITHHOLD | 5 | |
| Twist Bioscience Corporation | February 5, 2026 | Election of Class II Directors: Keith Crandell | Director Elections | Board | WITHHOLD | 5 | |
| UMS Integration Limited | April 30, 2026 | Adopt UMS Employee Share Option Scheme 2026 | Compensation | Board | AGAINST | 5 | |
| UMS Integration Limited | April 30, 2026 | Approve Grant of Options at a Discount under the UMS Employee Share Option Scheme 2026 | Compensation | Board | AGAINST | 5 | |
| UMS Integration Limited | April 30, 2026 | Approve Issuance of Equity or Equity-Linked Securities with or without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| USCB Financial Holdings, Inc. | May 26, 2026 | Election of Directors: NOMINEES for a one-year term expiring in 2027: Ramon Abadin | Director Elections | Board | WITHHOLD | 5 | |
| Ubisoft Entertainment SA | July 10, 2025 | Approve Issuance of Equity or Equity-Linked Securities for Private Placements, up to Aggregate Nominal Amount of EUR 1 Million | Capital Structure | Board | AGAINST | 5 | |
| Ubisoft Entertainment SA | July 10, 2025 | Authorize Issuance of Equity or Equity-Linked Securities without Preemptive Rights up to Aggregate Nominal Amount of EUR 1 Million | Capital Structure | Board | AGAINST | 5 | |
| Ubisoft Entertainment SA | July 10, 2025 | Elect Axelle Lemaire as Director | Director Elections | Board | AGAINST | 5 | |
| Ubisoft Entertainment SA | July 10, 2025 | Reelect Christian Guillemot as Director | Director Elections | Board | AGAINST | 5 | |
| Ubisoft Entertainment SA | July 10, 2025 | Reelect Michel Guillemot as Director | Director Elections | Board | AGAINST | 5 | |
| Uni-President China Holdings Ltd. | June 5, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| Uni-President China Holdings Ltd. | June 5, 2026 | Approve PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 5 | |
| Uni-President China Holdings Ltd. | June 5, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: A. M. Doumet | Director Elections | Board | WITHHOLD | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: J. A. Wolkenstein | Director Elections | Board | WITHHOLD | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: L. R. Weirich | Director Elections | Board | WITHHOLD | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: R. W. Cardin | Director Elections | Board | WITHHOLD | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: S. C. Duhe | Director Elections | Board | WITHHOLD | 5 | |
| United States Lime & Minerals, Inc. | May 1, 2026 | To elect Directors - Nominees: T. S. Hawkins, Jr. | Director Elections | Board | WITHHOLD | 5 | |
| United Therapeutics Corporation | June 26, 2026 | Approval of the United Therapeutics Corporation 2026 Stock Incentive Plan. | Compensation | Board | AGAINST | 5 | |
| Unity Software Inc. | May 13, 2026 | To elect each of the Board of Directors' three nominees for director named in the accompanying proxy statement, to serve as a Class III member of the Board of Directors until the 2029 Annual Meeting of Stockholders and until their successors are elected and qualified, subject to their earlier death, resignation or removal: Matthew Bromberg | Director Elections | Board | WITHHOLD | 5 | |
| Upstart Holdings, Inc. | May 28, 2026 | The approval, on an advisory basis, of the compensation of our named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| Valeura Energy Inc. | May 14, 2026 | Elect Director Chalermchai Mahagitsiri | Director Elections | Board | WITHHOLD | 5 | |
| Valeura Energy Inc. | May 14, 2026 | Re-approve Performance and Restricted Share Unit Plan | Compensation | Board | AGAINST | 5 | |
| Valeura Energy Inc. | May 14, 2026 | Re-approve Stock Option Plan | Compensation | Board | AGAINST | 5 | |
| Vanda Pharmaceuticals Inc. | June 4, 2026 | To elect three Class II Directors: Anne Sempowski Ward | Director Elections | Board | AGAINST | 5 | |
| Vanda Pharmaceuticals Inc. | June 4, 2026 | To elect three Class II Directors: Richard W. Dugan | Director Elections | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Appoint KPMG AG as Auditor for Sustainability Reporting for Fiscal Year 2025/26 | Audit-related | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Approve Remuneration Report | Compensation | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Elect Alexander von Witzleben to the Supervisory Board | Director Elections | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Elect Christian Doll as Alternate Supervisory Board Member | Director Elections | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Elect Klaus Niemann to the Supervisory Board | Director Elections | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Elect Ulrike Kraemer to the Supervisory Board | Director Elections | Board | AGAINST | 5 | |
| Verbio SE | December 5, 2025 | Ratify KPMG AG as Auditors for Fiscal Year 2025/26 | Audit-related | Board | AGAINST | 5 | |
| Vericel Corporation | April 29, 2026 | To approve, on an advisory basis, the compensation of Vericel Corporation's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| Verra Mobility Corporation | May 19, 2026 | Elect three Class II directors, Patrick J. Byrne, David M. Roberts, and John H. Rexford, to serve on our Board until our 2029 Annual Meeting of Stockholders: Patrick J. Byrne | Director Elections | Board | WITHHOLD | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Anne Sheehan | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Hillary Super | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Irene Chang Britt | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Jacqueline Hernandez | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Lauren Peters | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Rod Little | Director Elections | Board | AGAINST | 5 | |
| Victoria's Secret & Co. | June 11, 2026 | To elect nine directors to serve until the 2027 annual meeting of stockholders: Sarah Davis | Director Elections | Board | AGAINST | 5 | |
| Viking Therapeutics, Inc. | May 19, 2026 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| Viper Energy, Inc. | May 19, 2026 | The approval, on an advisory basis, of the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| Vir Biotechnology, Inc. | May 26, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board (inferred) | AGAINST | 5 | |
| Virtu Financial, Inc. | June 10, 2026 | Election of Directors: Joanne M. Minieri | Director Elections | Board | WITHHOLD | 5 | |
| Virtu Financial, Inc. | June 10, 2026 | Election of Directors: Joseph J. Grano, Jr. | Director Elections | Board | WITHHOLD | 5 | |
| Vitalhub Corp. | June 26, 2026 | Elect Director Barry Tissenbaum | Director Elections | Board | WITHHOLD | 5 | |
| Vitalhub Corp. | June 26, 2026 | Elect Director Tony Shen | Director Elections | Board | WITHHOLD | 5 | |
| Vobile Group Limited | June 26, 2026 | Adopt Share Incentive Plan, Plan Mandate Limit and Service Provider Sublimit | Compensation | Board | AGAINST | 5 | |
| Vobile Group Limited | June 26, 2026 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 | |
| Vobile Group Limited | June 26, 2026 | Authorize Reissuance of Repurchased Shares | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Amount and Usage of Raised Funds | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Authorization of the Board and its Authorized Persons to Handle Matters Related to Issuance of Shares to Specific Targets | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Company's Eligibility for Issuance of Shares to Specific Targets | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Demonstration Analysis Report in Connection to Issuance of Shares to Specific Targets | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Distribution Arrangement of Undistributed Earnings | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Establish a Special Account for Raised Funds | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Feasibility Analysis Report on the Use of Proceeds | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Issue Manner and Issue Time | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Issue Size | Capital Structure | Board | AGAINST | 5 | |
| Walvax Biotechnology Co., Ltd. | April 3, 2026 | Approve Issue Type and Par Value | Capital Structure | Board | AGAINST | 5 |
← Previous Page 50 of 61 Next →
← Back to Dimensional 2025-2026 overview
Built October 25, 2026 from SEC Form N-PX filings.